U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Asahi Kasei Medical Co. Ltd. - 04/07/2014
  1. Warning Letters


Asahi Kasei Medical Co. Ltd.

Asahi Kasei Medical Co. Ltd.

United States

Issuing Office:

United States


Department of Health and Human Services' logoDepartment of Health and Human Services

Public Health Service
 Food and Drug Administration
10903 New Hampshire Avenue
Silver Spring, MD 20993


April 7, 2014

Yutaka Shibata
Asahi Kasei Medical Co. Ltd.
2111-2 Oaza Sato
Oita Plant
Oita-shi, Japan

Dear Mr. Shibata:

The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter CMS 398405 dated June 11, 2013. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.




Steve D. Silverman
Office of Compliance
Center for Devices and
Radiological Health

Back to Top